The main goal of this study is to understand how different levels of anxiety change our mood, brain function, and general perceptions of our body.
A greater understanding of how anxiety changes the brain and body can help us develop anxiety treatments that are more effective, and understand why current treatments work better for some people.
We are currently recruiting individuals who are not currently engaged in organised sport or scheduled physical/fitness activity.
Link to the information sheet.
For more information:
Read through our study webpage
Contact us via our Recruitment email: exercise.anxiety@otago.ac.nz
One treatment that is known to typically improve anxiety symptoms is a type of drug called selective serotonin re-uptake inhibitors (SSRIs, e.g. citalopram, sertraline). Therefore, the main goal of this study is to understand how this type of treatment changes our mood, as well as general perceptions of our body and the rest of the world. This information will help us understand how the treatment works, and how we can best use it in the future to help people cope with their anxiety.
We are currently recruiting individuals who are in the first seven days of SSRI use or individuals who have been taking an SSRI for more than 3 months.
Contact our Recruitment email if you would like more information: recruitment.imageotago@otago.ac.nz
Ketamine is a medication that has been used for over 40 years for a variety of purposes. There is now growing evidence that low-dose ketamine can lead to an improvement in the symptoms associated with anxiety. In this clinical trial, we are seeking to validate ketamine as a viable treatment for the more severe versions of this disorder.
This study is specifically for individuals who have been diagnosed with anxiety, have tried numerous medications to assist their symptoms (such as various pharmacotherapy), and not currently experiencing symptoms of depression.
Contact our Recruitment email if you would like more information: recruitment.imageotago@otago.ac.nz